Revasum, Inc. reported earnings results for the half year ended July 03, 2022. For the half year, the company reported sales was USD 7.41 million compared to USD 4.61 million a year ago. Net loss was USD 5.32 million compared to USD 0.248 million a year ago.

Basic loss per share from continuing operations was USD 0.05.